scholarly article | Q13442814 |
review article | Q7318358 |
P6179 | Dimensions Publication ID | 1041384756 |
P356 | DOI | 10.1007/BF00711903 |
P8608 | Fatcat ID | release_i3ja2tzjvvda7djpzi3it4h4oa |
P698 | PubMed publication ID | 8105145 |
P2093 | author name string | A C Ludolph | |
K Ullrich | |||
M Riepe | |||
P2860 | cites work | Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs | Q28270170 |
NMDA Antagonist Neurotoxicity: Mechanism and Prevention | Q28273543 | ||
Inhibition of proteolysis protects hippocampal neurons from ischemia | Q30446773 | ||
Aminooxyacetic Acid Results in Excitotoxin Lesions by a Novel Indirect Mechanism | Q34756401 | ||
MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex | Q34767298 | ||
Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? | Q35254212 | ||
Excitotoxins: possible mechanisms of action | Q35260745 | ||
Synaptic excitation mediated by glutamate-gated ion channels | Q35261556 | ||
Molecular characteristics of excitatory amino acid receptors. | Q35262509 | ||
3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. | Q36934346 | ||
The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death | Q37585239 | ||
Activation of the metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures | Q37610923 | ||
Excitatory amino acid neurotoxicity and neurodegenerative disease | Q37989602 | ||
Neurotoxicity at the N-methyl-D-aspartate receptor in energy-compromised neurons. An hypothesis for cell death in aging and disease. | Q39528853 | ||
Excitatory Amino Acid Transmitters | Q40084320 | ||
Evidence that the loss of the voltage-dependent Mg2+ block at the N-methyl-D-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism | Q41096804 | ||
Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists | Q41154685 | ||
Hypothesis: a role for quinolinic acid in the neuropathology of glutaric aciduria type I. | Q41356760 | ||
Sulfite oxidase deficiency: clinical, neuroradiologic, and biochemical features in two new patients | Q41932055 | ||
Functional and morphological deficits in late-treated patients with homocystinuria: a clinical, electrophysiologic and MRI study | Q42471250 | ||
Antagonism of non-NMDA receptors augments the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen and glucose | Q43840051 | ||
A metabotropic glutamate receptor agonist does not mediate neuronal degeneration in cortical culture | Q46628360 | ||
L-homocysteic acid but not L-glutamate is an endogenous N-methyl-D-aspartic acid receptor preferring agonist in rat neocortical neurons in vitro | Q48194048 | ||
Actions of L- and D-homocysteate in rat CNS: a correlation between low-affinity uptake and the time courses of excitation by microelectrophoretically applied L-glutamate analogues | Q48267978 | ||
Inhibition of brain glutamate decarboxylase by glutarate, glutaconate, and β-Hydroxyglutarate: Explanation of the symptoms in glutaric aciduria? | Q48403320 | ||
Inhibition of energy metabolism by 3-nitropropionic acid activates ATP-sensitive potassium channels | Q48454957 | ||
Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats | Q48486405 | ||
Amino acids as central nervous transmitters: the influence of ions, amino acid analogues, and ontogeny on transport systems for L-glutamic and L-aspartic acids and glycine into central nervous synaptosomes of the rat. | Q48617709 | ||
Glutamate Neurotoxicity Is Independent of Calpain I Inhibition in Primary Cultures of Cerebellar Granule Cells | Q48651242 | ||
Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina | Q48699234 | ||
The structural specificity of the high affinity uptake of L-glutamate and L-aspartate by rat brain slices | Q48718631 | ||
In Vitro and In Vivo Pharmacology oftrans-andcis-(±)-1-Amino-1,3-Cyclopentanedicarboxylic Acid: Dissociation of Metabotropic and Ionotropic Excitatory Amino Acid Receptor Effects | Q48733375 | ||
Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels | Q48950195 | ||
Nonketotic hyperglycinemia: treatment with diazepam--a competitor for glycine receptors | Q51854885 | ||
Studies on the aetiology and pathogenesis of motor neuron diseases. 1. Lathyrism: clinical findings in established cases | Q57926355 | ||
Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition | Q67916419 | ||
Physiological and pathophysiological roles of excitatory amino acids during central nervous system development | Q68466342 | ||
Prenatal diagnosis of nonketotic hyperglycinemia | Q71579291 | ||
P433 | issue | 4 | |
P921 | main subject | excitotoxicity | Q901117 |
neurodegeneration | Q1755122 | ||
P304 | page(s) | 716-723 | |
P577 | publication date | 1993-01-01 | |
P1433 | published in | Journal of Inherited Metabolic Disease | Q6295359 |
P1476 | title | Excitotoxicity, energy metabolism and neurodegeneration | |
P478 | volume | 16 |
Q89848961 | Apoptotic Inducement of Neuronal Cells by Aluminium Chloride and the Neuroprotective Effect of Eugenol in Wistar Rats |
Q44487554 | Brain energy metabolism is compromised by the metabolites accumulating in homocystinuria |
Q42451548 | Effects of L-2-hydroxyglutaric acid on various parameters of the glutamatergic system in cerebral cortex of rats. |
Q42513135 | Effects of methylmalonic and propionic acids on glutamate uptake by synaptosomes and synaptic vesicles and on glutamate release by synaptosomes from cerebral cortex of rats |
Q77403432 | Human mitochondrial diseases: answering questions and questioning answers |
Q33881161 | Identification of 167 polymorphisms in 88 genes from candidate neurodegeneration pathways |
Q54472383 | Impaired tolerance to repetitive hypoxia in hippocampal slices of Cu,Zn superoxide dismutase transgenic mice. |
Q44404792 | Impairment of energy metabolism in hippocampus of rats subjected to chemically-induced hyperhomocysteinemia |
Q43921784 | Inhibition of the mitochondrial respiratory chain complex activities in rat cerebral cortex by methylmalonic acid. |
Q73211661 | Leber hereditary optic neuropathy. Electron microscopy and molecular genetic analysis of a case |
Q41678616 | Leber hereditary optic neuropathy: mitochondrial mutations and degeneration of the optic nerve |
Q42557604 | Mitochondrial gene mutations and human diseases: a prolegomenon |
Q41680052 | Neurological dysfunction in methylmalonic acidaemia is probably related to the inhibitory effect of methylmalonate on brain energy production |
Q33719819 | Neurotoxic mechanisms of degeneration in motor neuron diseases |
Q48775593 | Peripheral neuropathy in sleep apnea. A tissue marker of the severity of nocturnal desaturation. |
Q48389991 | Pharmacological evidence for GABAergic and glutamatergic involvement in the convulsant and behavioral effects of glutaric acid |
Q48224920 | Reduction in the MK-801 binding sites of the NMDA sub-type of glutamate receptor in a mouse model of congenital hyperammonemia: prevention by acetyl-L-carnitine |